about
The importance of integrating basic and clinical research toward the development of new therapies for Huntington diseaseA natural antisense transcript at the Huntington's disease repeat locus regulates HTT expressionAge-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington diseaseCorticostriatal Dysfunction in Huntington's Disease: The BasicsRole of cerebral cortex in the neuropathology of Huntington's diseaseIron dysregulation in Huntington's diseaseMouse models of polyglutamine diseases: review and data table. Part IStriatal cholinergic interneuron regulation and circuit effectsThe synaptic maintenance problem: membrane recycling, Ca2+ homeostasis and late onset degenerationMouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II.Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's diseaseGenetics and neuropathology of Huntington's diseaseImpaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's diseaseTurning it upside down: areas of preserved cognitive function in schizophrenia.Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.BDNF-TrkB signaling in striatopallidal neurons controls inhibition of locomotor behavior.A novel cognitive-neurophysiological state biomarker in premanifest Huntington's disease validated on longitudinal data.Time processing in Huntington's disease: a group-control studyWheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington's disease.Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease.Complexity and heterogeneity: what drives the ever-changing brain in Huntington's disease?Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of Huntington's Disease: Exercise, Adenosine Receptors and AmpakinesAltered Neuronal Dynamics in the Striatum on the Behavior of Huntingtin Interacting Protein 14 (HIP14) Knockout MiceA novel method for detecting 7-methyl guanine reveals aberrant methylation levels in Huntington diseaseDifferential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.Ceftriaxone-induced up-regulation of cortical and striatal GLT1 in the R6/2 model of Huntington's disease.Altered Ca(2+) signaling in skeletal muscle fibers of the R6/2 mouse, a model of Huntington's diseaseDysfunctional behavioral modulation of corticostriatal communication in the R6/2 mouse model of Huntington's diseaseDifferential electrophysiological changes in striatal output neurons in Huntington's disease.Striatal pre-enkephalin overexpression improves Huntington's disease symptoms in the R6/2 mouse model of Huntington's diseaseAction selection in a possible model of striatal medium spiny neuron dysfunction: behavioral and EEG data in a patient with benign hereditary chorea.Changes in striatal procedural memory coding correlate with learning deficits in a mouse model of Huntington diseaseFunctional Changes in Neocortical Activity in Huntington's Disease Model Mice: An in vivo Intracellular Study.Activated microglia proliferate at neurites of mutant huntingtin-expressing neuronsTreatment with a herbal formula B401 enhances neuroprotection and angiogenesis in the R6/2 mouse model of Huntington's disease.Forebrain striatal-specific expression of mutant huntingtin protein in vivo induces cell-autonomous age-dependent alterations in sensitivity to excitotoxicity and mitochondrial function.Differential Synaptic and Extrasynaptic Glutamate-Receptor Alterations in Striatal Medium-Sized Spiny Neurons of Aged YAC128 Huntington's Disease Mice.Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction.Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington's disease.Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington's Disease
P2860
Q22306292-5EB8DD05-C003-481A-919F-CBE4C7FA5DB3Q24620388-FE6DB43C-C86B-49EB-AF92-2AAA2C1A35B1Q24657764-54559F34-B786-433A-B12A-BF5AEBE96112Q26738379-6A87CF5C-40AF-45AF-AB49-62062269EF98Q26829211-A2BF3823-F6AE-46E5-8856-0AD8189D23A3Q26829932-55821D08-B9D9-4BB5-B71F-A42A2903D8FFQ26853025-7E916370-38EF-486F-8DF4-07BDE9AAD338Q26863113-B06D3281-1081-4A66-9F82-9A3159FBE69CQ27000356-E0501D6A-A3B9-4982-8EDE-C447E021826CQ27005950-0F7455B0-D871-4FB6-ADB2-247993BB9743Q27011417-46BB2D49-1C36-4115-B907-768EE91BC8C3Q27023050-0DA73766-A405-4BB1-9C7A-98173164B59EQ29144918-4DEE3C5B-0DF3-4F0B-A852-AAC21E883201Q30450648-CB5A82E8-C6BB-4E9C-9C01-844BAA108824Q30490632-EA5CF2E3-3825-40DA-9DAC-459336A35D76Q30573241-61936B48-90FE-45B2-BFBF-1120DC86A514Q30622209-7B2998B4-44AA-4556-BA9D-BD0739CF5BCBQ33308722-4BE970F2-7964-4E91-A7A0-F90E63DBCB16Q33326475-0207442D-3695-4470-885D-1DAD1D427CBBQ33573371-7133183E-EB7E-4D39-815F-690F484E19AEQ33619310-EE0C113B-D247-41C3-B8A8-91E3295B0806Q33705003-5836C6DC-9DAA-49D4-9CAB-E9DB41A5197EQ33772223-8D7DE0AD-ED26-4A2C-9E86-66BDD9F35E2CQ33874603-1A597AA2-AEF1-483E-A0ED-AEE8B326A28FQ33931283-ED646C88-31F7-4387-9526-6B5456049A5AQ34053585-FA3F0A74-802F-48E9-AD59-014D6349CE00Q34409630-A5DD507E-2551-40B3-96BA-2B87347B7400Q34442696-28B2158A-F31E-4A39-AFF1-21EBA9A762A1Q34764514-F1250AE1-9374-4B86-8180-136744927A8AQ34990529-7CC93FBD-C4A9-4B10-B929-AE34182F6B6CQ35019948-8C0103D9-7EFB-439E-B778-9215E00F58B7Q35022005-F17E1B86-2725-40F2-B2CD-2422653D378BQ35055109-20AE31E2-5679-46B2-B243-AF9D299C73DFQ35103285-F1614F6B-3F4E-46BC-8F3B-AF436E433F70Q35113275-A25B067E-4025-462A-A4CA-F0E46E95F80BQ35161675-9410AAC4-E123-473A-8CC6-999B6668F43BQ35181056-3FC4D282-50A5-40D5-AE90-96A1E8799C3DQ35487248-8C23C104-6987-43DB-AC97-EE10D8B54F80Q35560350-FD549096-A612-45BE-BCCA-76C01AF2A112Q35867178-261BB9A8-F1AB-4BC3-98F4-8BAD6D015293
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The corticostriatal pathway in Huntington's disease.
@ast
The corticostriatal pathway in Huntington's disease.
@en
type
label
The corticostriatal pathway in Huntington's disease.
@ast
The corticostriatal pathway in Huntington's disease.
@en
prefLabel
The corticostriatal pathway in Huntington's disease.
@ast
The corticostriatal pathway in Huntington's disease.
@en
P2093
P2860
P1476
The corticostriatal pathway in Huntington's disease.
@en
P2093
Carlos Cepeda
Damian M Cummings
Michael S Levine
Nanping Wu
Véronique M André
P2860
P304
P356
10.1016/J.PNEUROBIO.2006.11.001
P577
2006-12-13T00:00:00Z